Eco Animal Health Group (LON:EAH)‘s stock had its “buy” rating reiterated by equities researchers at Peel Hunt in a report issued on Thursday, ThisIsMoney.Co.Uk reports.
LON EAH opened at GBX 252 ($3.31) on Thursday. The company’s 50 day moving average is GBX 245.28 and its 200-day moving average is GBX 301.92. Eco Animal Health Group has a 12-month low of GBX 90 ($1.18) and a 12-month high of GBX 755 ($9.93). The company has a quick ratio of 2.26, a current ratio of 3.58 and a debt-to-equity ratio of 2.54. The firm has a market cap of $170.22 million and a P/E ratio of 18.95.
About Eco Animal Health Group
ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.
Further Reading: Risk Tolerance
Receive News & Ratings for Eco Animal Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eco Animal Health Group and related companies with MarketBeat.com's FREE daily email newsletter.